Medifast, Inc.
$12.18
The Read: Medifast's stock fell about 6% after Q4 2025 earnings disappointed, then surged about 28% on a strategic pivot, and rallied about 21% after Q1 2026 earnings showed a narrower loss, revenue beat, and operational turnaround signs.
Price
Overlays
Panel
MED
Hover to view data
No Data